Screener
Denali Therapeutics Inc. DNLI Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s current ratio?
- Denali Therapeutics Inc. (DNLI) reported current ratio of 8.4× in Q2 2026.
- How has Denali Therapeutics Inc.'s current ratio changed year-over-year?
- Denali Therapeutics Inc.'s current ratio decreased by 18.5% year-over-year, from 10.3× to 8.4×.
- What is the long-term trend for Denali Therapeutics Inc.'s current ratio?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s current ratio has grown at a -15.2% compound annual growth rate (CAGR), from 20.9× to 9.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Denali Therapeutics Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude